Results 251 to 260 of about 87,328 (317)

Long‐Term Clinical and Psychological Efficacy and Safety of Ocrelizumab in People With Multiple Sclerosis: A Real‐World Longitudinal Study

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Multiple sclerosis (MS) is the most prevalent immune‐mediated neurodegenerative disease affecting the central nervous system. Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, has demonstrated significant efficacy in reducing disease activity and improving clinical outcomes of people with MS (PwMS) in clinical trials. However,
Majid Jafari   +7 more
wiley   +1 more source

Cluster of Severe Arginase 1 Deficiency in the Comoros: Clinical, Neuroimaging, and Molecular Features in 17 Patients From Mayotte Compared With 10 From Paris

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.
ABSTRACT Arginase 1 deficiency (ARG1D) is the least common urea cycle disorder. Neonatal onset is rarely described, and hyperammonemic coma is less common in patients with ARG1D compared to other urea cycle disorders. In recent years, we diagnosed a high number of ARG1D patients in Mayotte, an insular (Comoro Islands) department of France.
Aurélie De Bruyne   +16 more
wiley   +1 more source

Genetic Diversity and Relationships Among Newly Developed Cowpea Mutant Lines Using SSR Markers and Agro‐Morphological Traits

open access: yesLegume Science, Volume 8, Issue 1, March 2026.
ABSTRACT Cowpea (Vigna unguiculata [L.] Walp.) is a drought‐resilient and protein‐rich legume of major importance in arid and semiarid regions, including Eswatini, where it contributes to food, feed, and nutritional security. The objective of this study was to assess the genetic diversity and relationships among 30 cowpea genotypes, comprising 24 ...
Kwazi A. K. Mkhonta   +2 more
wiley   +1 more source

Quantitative Systems Pharmacology Models of Anti‐Amyloid Treatments for Alzheimer's Disease: A Systematic Review

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 3, March 2026.
ABSTRACT Quantitative systems pharmacology (QSP) models have emerged as useful tools for evaluating the efficacy of Alzheimer's disease (AD) therapies. Bringing together a clinical focus with the mechanistic detail of systems biology, QSP models are well suited to the complexity of AD and have been used to predict treatment outcomes and support ...
Lara Herriott   +4 more
wiley   +1 more source

The protection of mesenchymal stem cells in metabolic reprogramming and endothelial-mesenchymal transition in diabetic aortas. [PDF]

open access: yesStem Cells Transl Med
Ling M   +13 more
europepmc   +1 more source

The predictive value of serum neurofilament light chain in achieving no evidence of disease activity-3 (NEDA-3) status in treatment-naïve patients with multiple sclerosis. [PDF]

open access: yesJ Neurol
Dimitriadou EM   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy